| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |